K-975 (K975) is the first covalent TEAD inhibitor that disrupt YAP/TAZ-TEAD protein-protein interaction, thus showing anticancer activity. K-975 acts by covalently binding to an internal cysteine residue located in the palmitate-binding pocket of TEAD.

纯度：≥98%

CAS：2563855-03-6